Panel Discussion | Renal Denervation: The Next Big Thing in Interventional Cardiology?

Tuesday, March 11, 2025

9:30 AM – 9:50 AM ET

Panel Moderator(s)

Lawrence Biegelsen, MBA

Managing Director Medical Supplies & Devices
Wells Fargo
Short Hills, New Jersey, United States

Disclosure(s): No financial relationships to disclose
Rick Wise, CFA

Research Analyst
Stifel
New York, New York, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Michael J. Bloch, MD

Medical Director, Vascular Care
Renown Institute for Heart and Vascular Health
reno, Nevada, United States

Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); baralogics: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); janssen: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SoniVie: Grant/Research Support (Ongoing)
Raoul I. Bonan, MD, FSCAI

Associate Professor of Medicine
Univerty of Montreal
Montreal, Quebec, Canada

Disclosure(s): Open Stent Solution: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)
JF

Jason Fontana, PhD

Vice President Marketing and Strategy
Medtronic, California, United States

Disclosure information not submitted.
Vijay Iyer, MD, PhD

Associate Professor
University at Buffalo
East Amherst, New York, United States

Disclosure(s): No financial relationships to disclose
Andrew SP Sharp, MD

Professor of Cardiology
University College Dublin
Dublin, Ireland

Disclosure(s): AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Rod S. Taylor, MSc, PhD

Professor of Population Health
University of Glasgow
G, United Kingdom

Disclosure(s): ReCoR: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
JW

Jason Weidman

Disclosure information not submitted.

Disclosure(s):

Lawrence Biegelsen, MBA: No financial relationships to disclose

Rick Wise, CFA: No financial relationships to disclose

Herbert D. Aronow, MD, MPH: Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)

Michael J. Bloch, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); baralogics: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); janssen: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SoniVie: Grant/Research Support (Ongoing)

Raoul I. Bonan, MD, FSCAI: Open Stent Solution: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Vijay Iyer, MD, PhD: No financial relationships to disclose

David E. Kandzari, MD, FACC, FSCAI: Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Ablative Solutions, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); DeepQure: Consulting Fees (e.g., advisory boards) (Ongoing); GoldenLeaf Medical: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Supira Medical: Consultant (Ongoing), Grant/Research Support (Ongoing)

Helen Reeve-Stoffer, PhD: Recor Medical: Employee (Ongoing)

Andrew SP Sharp, MD: AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Rod S. Taylor, MSc, PhD: ReCoR: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)